Adicet Bio, Inc. (ACET) Financials

ACET Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 169.4 million 29.3 million
Dec. 31, 2025 192.4 million 33.1 million
Sept. 30, 2025 140.5 million 31.3 million
June 30, 2025 163.0 million 29.6 million

ACET Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -21.5 million 1.3 million
Dec. 31, 2025 -20.9 million 5.7 million
Sept. 30, 2025 -22.5 million 2.5 million
June 30, 2025 -26.7 million 2.9 million

ACET Net Income

No data available :(

ACET Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 137.6 million - 11.0 million
Dec. 31, 2025 158.5 million - 14.7 million
Sept. 30, 2025 103.1 million - 12.3 million
June 30, 2025 125.0 million - 15.4 million

ACET Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 10.7 million
Dec. 31, 2025 6.9 million
Sept. 30, 2025 5.7 million
June 30, 2025 5.7 million

ACET Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 37000 17.5 million 4.1 million -
Dec. 31, 2025 10000 25.0 million 6.9 million -
Sept. 30, 2025 209000 22.9 million 5.1 million -
June 30, 2025 47000 28.4 million 4.0 million -

ACET Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - 1.3 million
Dec. 31, 2025 - 1.5 million
Sept. 30, 2025 - 1.6 million
June 30, 2025 - 1.6 million

ACET Revenue by Segment
Graph available only for paid members. Upgrade to see it.

ACET

Price: $8.10

52 week price:
6.01
17.44

Payout Ratio Range:
-77.99%
-7.54%

Earnings Per Share: -13.87 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 400300

Ebitda: 12.8 million

Market Capitalization: 77.5 million

Links: